Skip to main content
. 2005 Dec;73(12):8119–8129. doi: 10.1128/IAI.73.12.8119-8129.2005

TABLE 1.

Median antibody titers after three immunizations of C57BL/6 mice with recombinant MSP2 and MSP119 proteins

Immunizing antigen Median midpoint titer (105) (95% CI)a
Mean IgG1/IgG2b ratiob P (MSP2 vs MSP119)
Total IgG IgG1 IgG2a IgG2b IgG3
MSP119 8.34 (2.19) 5.02 (1.97) 0.08 (0.41) 3.89 (0.52) 0.05 (0.13) 2.89
Serogroup A
    Full length (MSP2A) 9.60 (1.79) 6.34 (1.66) 0.83 (0.44) 2.95 (0.37) 0.43 (0.18) 4.69 0.008
    Di-A 17.8 (3.57) 2.55 (1.43) 0.18 (0.09) 12.0 (3.09) 0.11 (0.08) 0.32 0.007
    Poly-A 0.64 (0.30) 0.19 (0.12) 0.04 (0.02) 0.47 (0.12) 0.03 (0.02) 0.51 0.011
Serogroup B
    Full length (MSP2B) 19.3 (4.55) 11.8 (2.58) 0.78 (0.41) 3.91 (1.38) 0.51 (0.13) 5.92 0.014
    Di-B 3.84 (1.89) 0.76 (0.47) 0.04 (0.01) 2.50 (1.25) 0.03 (0.03) 0.34 0.009
    Poly-B 5.5 (0.63) 1.11 (0.88) 0.07 (0.05) 4.37 (1.25) 0.03 (0.01) 0.44 0.008
Con-C 2.61 (0.28) 0.18 (0.12) 0.08 (0.06) 2.22 (0.63) 0.06 (0.03) 0.18 0.006
Con-N 0.64 (0.11) 0.45 (0.08) 0.02 (0.01) 0.42 (0.10) 0.01 (0.01) 1.46 0.064
a

There were six mice per group. 95% CI, 95% confidence interval.

b

Calculated as the mean for each mouse. Shown are the mean ratios of IgG1 to IgG2b (the IgG1/IgG2b index) and comparisons between the IgG1/IgG2b index for MSP2 proteins and the index for MSP119 (Wilcoxon rank sum tests).

HHS Vulnerability Disclosure